Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth

被引:115
|
作者
Takeda, K
Smyth, MJ
Cretney, E
Hayakawa, Y
Yamaguchi, N
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Peter MacCallum Canc Inst, Sir Donald & Lady Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia
[3] Toyama Med & Pharmaceut Univ, Res Inst Nat Med, Dept Pathogan Biochem, Toyama 9300194, Japan
[4] Juntendo Univ, Sch Med, Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan
基金
英国医学研究理事会;
关键词
TRAIL; NK cells; IFN-gamma; tumor growth;
D O I
10.1006/cimm.2001.1896
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NK) cells and interferon- (IFN) gamma have been implicated in immune surveillance against tumor development. Here we show tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which is a type II membrane protein belonging to the TNF family and plays a critical role in the NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous growth of TRAIL-sensitive tumors. Administration of a neutralizing monoclonal antibody against TRAIL promoted outgrowth of subcutaneously inoculated TRAIL-sensitive tumors (L929, LB27.4, and Renca) but not TRAIL-resistant tumors (P815 and 1316). Such a protective effect of TRAIL against TRAIL-sensitive tumors was abrogated in NK cell-depleted or IFN-gamma-deficient mice. These results suggested a substantial role of TRAIL as the effector molecule that eliminates subcutaneously developing TRAIL-sensitive tumors. (C) 2001 Elsevier Science (USA).
引用
收藏
页码:194 / 200
页数:7
相关论文
共 50 条
  • [41] Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis
    Wang, SH
    Cao, ZY
    Wolf, JM
    Van Antwerp, M
    Baker, JR
    ENDOCRINOLOGY, 2005, 146 (11) : 4721 - 4726
  • [42] Sensitization of human granulosa tumor cell lines to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Woods, Dori
    Johnson, Alan
    BIOLOGY OF REPRODUCTION, 2007, : 213 - 213
  • [43] Tumor necrosis factor-related apoptosis-inducing ligand induces, apoptosis in human articular chondrocytes in vitro
    Pettersen, I
    Figenschau, Y
    Olsen, E
    Bakkelund, W
    Smedsröd, B
    Sveinbjörnsson, B
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (03) : 671 - 676
  • [44] Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Elmallah, Mohammed I. Y.
    Micheau, Olivier
    MARINE DRUGS, 2015, 13 (11) : 6884 - 6909
  • [45] Sensitization for tumor necrosis factor-related apoptosis-inducing ligand induced apoptosis by the chemopreventive agent resveratrol
    Fulda, S
    Debatin, KM
    CANCER RESEARCH, 2004, 64 (01) : 337 - 346
  • [46] Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo
    Song, Keli
    Benhaga, Nordine
    Anderson, Robin L.
    Khosravi-Fari, Roya
    CANCER RESEARCH, 2006, 66 (12) : 6304 - 6311
  • [47] Tumor necrosis factor-related apoptosis-inducing ligand can induce apoptosis in subsets of premalignant cells
    Lu, XJ
    Arbiser, JL
    West, J
    Hoedt-Miller, M
    Sheridan, A
    Govindarajan, B
    Harral, JW
    Rodman, DM
    Fouty, B
    AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05): : 1613 - 1620
  • [48] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates tumor immune evasion in cholangiocarcinoma.
    Loeuillard, Emilien
    Yang, Jingchun
    Dong, Haidong
    Gores, Gregory J.
    Ilyas, Sumera
    CANCER RESEARCH, 2021, 81 (13)
  • [49] The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
    Horinaka, M
    Yoshida, T
    Shiraishi, T
    Nakata, S
    Wakada, M
    Sakai, T
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) : 945 - 951
  • [50] Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
    Takeda, K
    Smyth, MJ
    Cretney, E
    Hayakawa, Y
    Kayagaki, N
    Yagita, H
    Okumura, K
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (02): : 161 - 169